Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Quest Diagnostics Inc

DGX ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Healthcare Facilities & Services ·

USA Large Cap Analyst: BUY

Last Close

$244.39

▲ +1.28%

Market Cap $26.97B · Vol 626.47K

Key Metrics

P/E Ratio

25.98

FWD: 20.87

Market Cap

$26.97B

Large Cap

Div Yield

1.43%

Quarterly dividend

EPS Growth

+13.61%

YoY

RSI (14)

78.14

Momentum

Beta

0.55

vs Market

52W High

$245.50

0.45% below

52W Low

$171.42

42.57% above

Volume

626.47K

Avg 303.02K

P/B

2.66

Price-to-book

ROE

16.03%

Return on equity

Free Float

99.49%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Quest Diagnostics Inc (DGX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DGX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.26%

+18.15%

+26.09%

+20.74%

YTD

+40.83%

+33.02%

+84.61%

+60.78%

Financials & Valuation

TTM · Annual

Total Revenue	$11.04B
Net Income	$1.00B
Revenue Growth (YoY)	+10.21%
Gross Margin	31.93%
Operating Margin	15.05%
Net Profit Margin	9.48%
ROE	16.03%
ROA · ROIC	8.14% · 9.10%

P/E Ratio	25.98
Forward P/E (FY1)	20.87
PEG Ratio	1.41
P/S	1.78
P/B	2.66
P/FCF	14.43
EPS Growth	+13.61%
Outstanding Shares	110.37M

Technical Indicators

50-Day SMA	$219.31
200-Day SMA	$198.18
RSI (14)	78.14
Beta	0.55
52-Week High	$245.50
52-Week Low	$171.42

Volume Today	626.47K
Avg Daily Volume (30D)	303.02K
Relative Volume	2.07x
Volatility (10D)	13.96
Volatility (30D)	28.93
Free Float	99.49%

Analyst Consensus

BUY

Current Price $244.39

Mean Target $243.82

52W Low$171.42 52W High$245.50

Current

Target

$171.42 $245.50

Current Analyst target

-0.23% downside risk · 20 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S9GX43

ISINUS74834L1008

CountryUnited States of America

Sub-IndustryHealthcare Facilities & Services (NEC)

Earnings DateOct 19, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

FRE.DE Fresenius SE & Co KGaA +0.83% 4013.SE Dr Sulaiman Al Habib Medical Services Group Company SJSC -0.25% UHS Universal Health Services Inc +2.54% MAXHEALTH.NS Max Healthcare Institute Ltd +0.21% CHE Chemed Corp +1.06%

Company Profile

Quest Diagnostics Incorporated is a provider of diagnostic information services. It provides diagnostic insights from the results of its laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and its connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. Its other customers include health plans, employers, emerging retail healthcare providers, government agencies, and others. Its services are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.